Terkko Navigator / Cancer Letters

p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma

Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis

Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth

The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies

Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis

Mortalin depletion induces MEK/ERK-dependent and ANT/CypD-mediated death in vemurafenib-resistant B-RafV600E melanoma cells

Long non-coding RNAs at work on telomeres: Functions and implications in cancer therapy

FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα

Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives

COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice

ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells

Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer

Angio-associated migratory cell protein (AAMP) interacts with cell division cycle 42 (CDC42) and enhances migration and invasion in human non-small cell lung cancer cells

LncRNAs in cancer: Regulatory and therapeutic implications

Splicing factors: Insights into their regulatory network in alternative splicing in cancer

Cancer-associated 53BP1 mutations induce DNA damage repair defects

Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer

The potential of long noncoding RNAs for precision medicine in human cancer

Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer

The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment

Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer

Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma

Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes

Helper T cells in malignant pleural effusion

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer

lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma

Corrigendum to “Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22” [Canc. Lett. 340 (1) (Oct 28, 2013) 72–81]

Corrigendum to ‘miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway’[Cancer Lett. 2017 Nov 1;408:23–32]

Corrigendum to “Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells” [Canc. Lett. 466 (2019) 1–12]

Corrigendum to “Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy” [Canc. Lett 244 (2006) 182–189]

Corrigendum to ‘ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2’ [Canc. Lett. 427 (2018) 9-17]

Corrigendum to “Blocking exposed PD-L1 elicited by nanosecond pulsed electric field reverses dysfunction of CD8 + T cells in liver cancer” [Canc. Lett. 495 (2020) 1–11]

Corrigendum to “cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells” [Canc. Lett. 403 (2017) 260–270]

Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential

Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy

Mini review: Personalization of the radiation therapy management of prostate cancer using MRI-based radiomics

T-cell-based immunotherapy in colorectal cancer

Macrophages in pancreatic cancer: An immunometabolic perspective

Sex differences in health and disease: A review of biological sex differences relevant to cancer with a spotlight on glioma

LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival

Corrigendum to “FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway” [Canc. Lett. 363 (2015) 166–175]

TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1

Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3

Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice

Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model

PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2

EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation

HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma